Cote d'Ivoire vs Tanzania: Treatment coverage for schistosomiasis
Cote d'Ivoire
27.2%
in 2024
Tanzania
35.7%
in 2024
Cote d'Ivoire rank
38th
Tanzania rank
35th
Treatment coverage for schistosomiasis over time
- Cote d'Ivoire
- Tanzania
How they compare
Tanzania currently reports 35.7% against 27.2% in Cote d'Ivoire, a difference of 8.5%.
That makes Tanzania's figure about 1.3 times Cote d'Ivoire's.
The two have swapped places 4 times across 14 shared years of data; in 2009 it was Tanzania ahead.
Cote d'Ivoire ranks 38th and Tanzania ranks 35th of 45 countries.
Across the 3 decades both report, Cote d'Ivoire averaged higher in 2 and Tanzania in 1.
Head to head by decade
| Decade | Cote d'Ivoire | Tanzania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.1% | 0.6% | 0.6% | Tanzania |
| 2010s | 37.2% | 34.6% | 2.7% | Cote d'Ivoire |
| 2020s | 49.4% | 29.2% | 20.3% | Cote d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for schistosomiasis, Cote d'Ivoire or Tanzania?
- Tanzania, at 35.7% against 27.2% in Cote d'Ivoire as of 2024.
- What is the difference in treatment coverage for schistosomiasis between Cote d'Ivoire and Tanzania?
- 8.5%, with Tanzania ahead.
- How many years of comparable data are there for Cote d'Ivoire and Tanzania?
- 14 years are reported by both, from 2009 to 2024.
- How do Cote d'Ivoire and Tanzania rank globally for treatment coverage for schistosomiasis?
- Cote d'Ivoire ranks 38th and Tanzania ranks 35th of 45 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Treatment coverage for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.